Alector Inc ALEC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/17/21 EDT
21.37quote price arrow up+21.37 (UNCH)
Volume
5,931
Close
21.37quote price arrow down-1.06 (-4.73%)
Volume
521,578
52 week range
9.12 - 33.82

...

Loading . . .
  • Open22.40
  • Day High22.50
  • Day Low20.79
  • Prev Close21.37
  • 52 Week High33.82
  • 52 Week High Date06/23/20
  • 52 Week Low9.12
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap1.705B
  • Shares Out79.77M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change41.24

KEY STATS

  • Open22.40
  • Day High22.50
  • Day Low20.79
  • Prev Close21.37
  • 52 Week High33.82
  • 52 Week High Date06/23/20
  • 52 Week Low9.12
  • 52 Week Low Date10/30/20
  • Market Cap1.705B
  • Shares Out79.77M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change41.24

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-8.33
  • Fwd P/E (NTM)-7.40
  • EBITDA (MRQ)-199.766M
  • ROE (MRQ)-65.33%
  • Revenue (MRQ)18.04M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-1,122.03%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alector Inc

There is no recent news for this security.

Profile

MORE
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologies that are drivers of degenerative brain disorders. The Company is developing therapies designed to simultaneously counteract these pathologies by restoring healthy immune function to the brain. The Company's platform leverages...
Tillman Gerngross Ph.D.
Chairman
Arnon Rosenthal Ph.D.
Chief Executive Officer
Shehnaaz Suliman M.D.
President
Calvin Yu
Vice President - Finance
Address
151 Oyster Point Blvd Ste 300
South San Francisco, CA
94080-1841
United States

Top Peers

SYMBOLLASTCHG%CHG
YMAB
Y-mAbs Therapeutics Inc
37.64+1.86+5.20%
REPL
Replimune Group Inc
34.70+0.22+0.64%
AMTI
Applied Molecular Transport Inc.
44.53-5.42-10.85%
GBIO
Generation Bio Co
25.62-1.07-4.01%
CNST
Constellation Pharmaceuticals Inc
33.82+0.13+0.39%